Asarfi Hospital Limited (BOM:543943)
India · Delayed Price · Currency is INR 191.90
-7.05 (-3.54%)
At close: Sep 11, 2026
Asarfi Hospital Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,776 | 3,336 | 1,631 | 1,286 | - | - | |
Market Cap Growth | 27.76% | 104.50% | 26.91% | - | - | - |
Enterprise Value | 4,242 | 3,709 | 1,901 | 1,376 | - | - |
Last Close Price | 191.90 | 169.55 | 82.91 | 65.33 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 21.21 | 20.02 | 15.43 | 30.89 | - | - |
PS Ratio | 2.04 | 1.92 | 1.35 | 1.52 | - | - |
PB Ratio | 3.71 | 3.42 | 2.02 | 1.83 | - | - |
P/TBV Ratio | 3.71 | 3.42 | 2.02 | 1.83 | - | - |
P/FCF Ratio | - | 1710.92 | - | - | - | - |
P/OCF Ratio | 22.90 | 18.23 | - | 4.93 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.29 | 2.14 | 1.58 | 1.63 | - | - |
EV/EBITDA Ratio | 11.24 | 10.51 | 8.07 | 8.56 | - | - |
EV/EBIT Ratio | 16.29 | 15.63 | 17.49 | 18.91 | - | - |
EV/FCF Ratio | - | 1902.10 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.54 | 0.59 | 0.60 | 0.45 | 0.41 | 0.51 |
Debt / EBITDA Ratio | 1.45 | 1.63 | 2.06 | 1.99 | 1.25 | 1.08 |
Debt / FCF Ratio | - | 295.17 | - | - | - | - |
Net Debt / Equity Ratio | 0.46 | 0.46 | 0.41 | 0.22 | 0.21 | -0.09 |
Net Debt / EBITDA Ratio | 1.24 | 1.26 | 1.41 | 0.96 | 0.63 | -0.19 |
Net Debt / FCF Ratio | -11.90 | 228.21 | -2.06 | -0.77 | -0.39 | 0.20 |
Asset Turnover | 1.01 | 0.97 | 0.76 | 0.68 | 0.91 | 1.30 |
Inventory Turnover | 24.15 | 23.76 | 23.02 | 21.72 | 26.97 | 37.43 |
Quick Ratio | 1.41 | 1.37 | 1.35 | 0.92 | 1.30 | 1.29 |
Current Ratio | 1.49 | 1.45 | 1.43 | 1.03 | 1.86 | 1.50 |
Return on Equity (ROE) | 19.15% | 18.65% | 13.97% | 7.41% | 24.87% | 28.98% |
Return on Assets (ROA) | 8.88% | 8.31% | 4.27% | 3.68% | 7.92% | 9.30% |
Return on Invested Capital (ROIC) | 13.46% | 13.91% | 8.03% | 7.12% | 20.51% | 29.20% |
Return on Capital Employed (ROCE) | 17.50% | 16.50% | 8.80% | 6.60% | 13.40% | 15.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.72% | 4.99% | 6.48% | 3.24% | - | - |
FCF Yield | -1.04% | 0.06% | -9.89% | -15.56% | - | - |
Buyback Yield / Dilution | 0.07% | 0.03% | -9.02% | -70.59% | -41.13% | - |